Shalby Share Price
Sector: Healthcare Facilities
181.80 -0.90 (-0.49%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
181.65
Today’s High
185.40
52 Week Low
177.20
52 Week High
325.00
182.46 -0.48 (-0.26%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
181.10
Today’s High
185.62
52 Week Low
177.25
52 Week High
325.00
Key Metrics
- Market Cap (In Cr) 1956.68
- Beta 0.93
- Div. Yield (%) 0
- P/B 1.98
- TTM P/E 504.57
- Peg Ratio -9.13
- Sector P/E 22.44
- D/E 0
- Open Price 185
- Prev Close 182.7
Shalby Analysis
Price Analysis
-
1 Week0.84%
-
3 Months-6.82%
-
6 Month-20.68%
-
YTD-20.34%
-
1 Year-32.38%
Risk Meter
- 35% Low risk
- 35% Moderate risk
- 35% Balanced Risk
- 35% High risk
- 35% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Buy
- 1
- 1
- 1
- 1
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 1
- 1
- 1
- 1
Shalby News
Stocks to Watch: Adani Ent, HUDCO, Maruti Suzuki, Cipla, Canara Bank, and more
5 min read . 30 Oct 2024Stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks
2 min read . 08 Jul 2024Shalby Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 1086.96
- Selling/ General/ Admin Expenses Total
- 184.58
- Depreciation/ Amortization
- 65.76
- Other Operating Expenses Total
- 134.8
- Total Operating Expense
- 1020.11
- Operating Income
- 66.85
- Net Income Before Taxes
- 55.73
- Net Income
- 6.22
- Diluted Normalized EPS
- 0.58
- Period
- 2025
- Total Assets
- 1703.65
- Total Liabilities
- 711.47
- Total Equity
- 992.19
- Tangible Book Valueper Share Common Eq
- 84.95
- Period
- 2025
- Cashfrom Operating Activities
- -4.34
- Cashfrom Investing Activities
- -35.64
- Cashfrom Financing Activities
- 47.58
- Net Changein Cash
- 7.6
- Period
- 2024
- Total Revenue
- 933.95
- Selling/ General/ Admin Expenses Total
- 248.41
- Depreciation/ Amortization
- 52.24
- Other Operating Expenses Total
- 1.03
- Total Operating Expense
- 806.92
- Operating Income
- 127.03
- Net Income Before Taxes
- 128.19
- Net Income
- 84.08
- Diluted Normalized EPS
- 7.82
- Period
- 2024
- Total Assets
- 1607.53
- Total Liabilities
- 607.16
- Total Equity
- 1000.37
- Tangible Book Valueper Share Common Eq
- 86.15
- Period
- 2024
- Cashfrom Operating Activities
- 127.56
- Cashfrom Investing Activities
- 38.07
- Cashfrom Financing Activities
- -150.69
- Net Changein Cash
- 14.94
- Period
- 2023
- Total Revenue
- 804.92
- Selling/ General/ Admin Expenses Total
- 228.05
- Depreciation/ Amortization
- 48.09
- Other Operating Expenses Total
- 1.08
- Total Operating Expense
- 712.33
- Operating Income
- 92.6
- Net Income Before Taxes
- 102.04
- Net Income
- 67.7
- Diluted Normalized EPS
- 6.31
- Period
- 2023
- Total Assets
- 1281.36
- Total Liabilities
- 353.68
- Total Equity
- 927.69
- Tangible Book Valueper Share Common Eq
- 84.44
- Period
- 2023
- Cashfrom Operating Activities
- 67.79
- Cashfrom Investing Activities
- -61.08
- Cashfrom Financing Activities
- -50.02
- Net Changein Cash
- -43.31
- Period
- 2022
- Total Revenue
- 698.94
- Selling/ General/ Admin Expenses Total
- 345.71
- Depreciation/ Amortization
- 42.87
- Other Operating Expenses Total
- 190.08
- Total Operating Expense
- 625.2
- Operating Income
- 73.75
- Net Income Before Taxes
- 79.15
- Net Income
- 54.13
- Diluted Normalized EPS
- 5.32
- Period
- 2022
- Total Assets
- 1193.54
- Total Liabilities
- 317.22
- Total Equity
- 876.32
- Tangible Book Valueper Share Common Eq
- 79.19
- Period
- 2022
- Cashfrom Operating Activities
- 18.92
- Cashfrom Investing Activities
- -60.28
- Cashfrom Financing Activities
- 90.46
- Net Changein Cash
- 49.1
- Period
- 2021
- Total Revenue
- 430.9
- Selling/ General/ Admin Expenses Total
- 190.58
- Depreciation/ Amortization
- 36.8
- Other Operating Expenses Total
- 46.55
- Total Operating Expense
- 377.64
- Operating Income
- 53.26
- Net Income Before Taxes
- 55.05
- Net Income
- 42.4
- Diluted Normalized EPS
- 4.14
- Period
- 2021
- Total Assets
- 996.62
- Total Liabilities
- 161.97
- Total Equity
- 834.65
- Tangible Book Valueper Share Common Eq
- 75.69
- Period
- 2021
- Cashfrom Operating Activities
- 79.15
- Cashfrom Investing Activities
- -51.27
- Cashfrom Financing Activities
- -29.86
- Net Changein Cash
- -1.98
- Period
- 2020
- Total Revenue
- 486.85
- Selling/ General/ Admin Expenses Total
- 232.9
- Depreciation/ Amortization
- 36.02
- Other Operating Expenses Total
- 46.47
- Total Operating Expense
- 440.39
- Operating Income
- 46.46
- Net Income Before Taxes
- 56.73
- Net Income
- 27.59
- Diluted Normalized EPS
- 2.56
- Period
- 2020
- Total Assets
- 966.63
- Total Liabilities
- 167.46
- Total Equity
- 799.17
- Tangible Book Valueper Share Common Eq
- 72.67
- Period
- 2020
- Cashfrom Operating Activities
- 55.37
- Cashfrom Investing Activities
- -30.67
- Cashfrom Financing Activities
- -21.5
- Net Changein Cash
- 3.21
- Period
- 2019
- Total Revenue
- 462.26
- Selling/ General/ Admin Expenses Total
- 219.39
- Depreciation/ Amortization
- 33.17
- Other Operating Expenses Total
- 47.58
- Total Operating Expense
- 412.45
- Operating Income
- 49.81
- Net Income Before Taxes
- 50.39
- Net Income
- 31.66
- Diluted Normalized EPS
- 2.93
- Period
- 2019
- Total Assets
- 939.16
- Total Liabilities
- 159.37
- Total Equity
- 779.79
- Tangible Book Valueper Share Common Eq
- 71.07
- Period
- 2019
- Cashfrom Operating Activities
- 43.4
- Cashfrom Investing Activities
- 1.39
- Cashfrom Financing Activities
- -51.25
- Net Changein Cash
- -6.45
- Period
- 2025-03-31
- Total Revenue
- 264.89
- Selling/ General/ Admin Expenses Total
- 44.81
- Depreciation/ Amortization
- 16.23
- Other Operating Expenses Total
- 33.68
- Total Operating Expense
- 260.28
- Operating Income
- 4.61
- Net Income Before Taxes
- -0.74
- Net Income
- -11.02
- Diluted Normalized EPS
- -1.02
- Period
- 2025-03-31
- Total Assets
- 1703.65
- Total Liabilities
- 711.47
- Total Equity
- 992.19
- Tangible Book Valueper Share Common Eq
- 84.95
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -4.34
- Cashfrom Investing Activities
- -35.64
- Cashfrom Financing Activities
- 47.58
- Net Changein Cash
- 7.6
- Period
- 2024-12-31
- Total Revenue
- 275.63
- Selling/ General/ Admin Expenses Total
- 47.82
- Depreciation/ Amortization
- 16.32
- Other Operating Expenses Total
- 40.69
- Total Operating Expense
- 258.04
- Operating Income
- 17.59
- Net Income Before Taxes
- 12.35
- Net Income
- -1.81
- Diluted Normalized EPS
- -0.28
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 267.54
- Selling/ General/ Admin Expenses Total
- 47.11
- Depreciation/ Amortization
- 16.84
- Other Operating Expenses Total
- 33.64
- Total Operating Expense
- 251.73
- Operating Income
- 15.81
- Net Income Before Taxes
- 13.7
- Net Income
- 3.39
- Diluted Normalized EPS
- 0.32
- Period
- 2024-09-30
- Total Assets
- 1716.61
- Total Liabilities
- 709.99
- Total Equity
- 1006.61
- Tangible Book Valueper Share Common Eq
- 86.6
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 11.46
- Cashfrom Investing Activities
- -57.06
- Cashfrom Financing Activities
- 55.18
- Net Changein Cash
- 9.57
- Period
- 2024-06-30
- Total Revenue
- 278.89
- Selling/ General/ Admin Expenses Total
- 44.85
- Depreciation/ Amortization
- 16.37
- Other Operating Expenses Total
- 26.79
- Total Operating Expense
- 250.05
- Operating Income
- 28.84
- Net Income Before Taxes
- 30.41
- Net Income
- 15.66
- Diluted Normalized EPS
- 1.38
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 244.43
- Selling/ General/ Admin Expenses Total
- 39.93
- Depreciation/ Amortization
- 15.6
- Other Operating Expenses Total
- 29.94
- Total Operating Expense
- 221.17
- Operating Income
- 23.26
- Net Income Before Taxes
- 21.78
- Net Income
- 16.6
- Diluted Normalized EPS
- 1.55
- Period
- 2024-03-31
- Total Assets
- 1607.53
- Total Liabilities
- 607.16
- Total Equity
- 1000.37
- Tangible Book Valueper Share Common Eq
- 86.15
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 127.56
- Cashfrom Investing Activities
- 38.07
- Cashfrom Financing Activities
- -150.69
- Net Changein Cash
- 14.94
- Period
- 2023-12-31
- Total Revenue
- 216.05
- Selling/ General/ Admin Expenses Total
- 37.76
- Depreciation/ Amortization
- 12.4
- Other Operating Expenses Total
- 18.94
- Total Operating Expense
- 186.12
- Operating Income
- 29.93
- Net Income Before Taxes
- 30.81
- Net Income
- 19.07
- Diluted Normalized EPS
- 1.78
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Shalby Technical
Moving Average
SMA
- 5 Day181.77
- 10 Day182.03
- 20 Day183.5
- 50 Day189.36
- 100 Day196.19
- 300 Day220.87
Shalby Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Krsnaa Diagnostics
- 696.9
- -4.9
- -0.7
- 1041.8
- 600.4
- 2248.84
- Dr. Agarwal's Eye Hospital
- 4312
- -4.4
- -0.1
- 7300
- 3114.3
- 2017.95
- Shalby
- 181.8
- -0.9
- -0.49
- 325
- 177.2
- 1956.68
- Gpt Healthcare
- 147.1
- 1.3
- 0.89
- 206.5
- 126.15
- 1204.57
- Kerala Ayurveda
- 585
- 47.4
- 8.82
- 559
- 250
- 703.9
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Krsnaa Diagnostics
- 29.94
- 2.58
- 16.02
- 16.81
- Dr. Agarwal's Eye Hospital
- 34.9
- 9.67
- 29.95
- 12.12
- Shalby
- 316.69
- 1.98
- 5.61
- 6.31
- Gpt Healthcare
- 24.16
- 4.86
- 23.1
- 11.41
- Kerala Ayurveda
- -
- 68.45
- -33.05
- -3.81
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-25
- Audited Results & Final Dividend
- 03-Feb-25
- Quarterly Results & Others
- 30-Oct-24
- Quarterly Results
- 08-Jul-24
- Quarterly Results
- 28-May-24
- Audited Results & Final Dividend
- 07-Feb-24
- Quarterly Results
- 27-Oct-23
- Quarterly Results
- 20-Jul-23
- Quarterly Results
- 18-May-23
- Audited Results & Final Dividend
- 15-May-23
- Audited Results & Final Dividend
- Meeting Date
- Announced on
- Purpose
- 16-Mar-25
- 10-Feb-25
- POM
- 26-Sept-24
- 23-Aug-24
- AGM
- 20-Aug-23
- 13-Jul-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-24
- -
- 19-Sept-24
- 1.2
- 18-May-23
- -
- 08-Aug-23
- 1.2
- 25-May-22
- -
- 19-Sept-22
- 1
- 05-May-21
- -
- 17-Sept-21
- 1


